These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3552069)

  • 1. Supplementary analysis at the conclusion of a sequential clinical trial.
    Whitehead J
    Biometrics; 1986 Sep; 42(3):461-71. PubMed ID: 3552069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trials.
    Thall PF; Russell KE
    Biometrics; 1998 Mar; 54(1):251-64. PubMed ID: 9544520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sequential procedure for monitoring clinical trials against historical controls.
    Xiong X; Tan M; Boyett J
    Stat Med; 2007 Mar; 26(7):1497-511. PubMed ID: 16900551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated significance tests for clinical trials with a fixed number of patients and variable follow-up.
    Armitage P; Stratton IM; Worthington HV
    Biometrics; 1985 Jun; 41(2):353-9. PubMed ID: 4027318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group sequential clinical trials with triangular continuation regions.
    Whitehead J; Stratton I
    Biometrics; 1983 Mar; 39(1):227-36. PubMed ID: 6871351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for monitoring efficacy and toxicity responses in clinical trials.
    Cook RJ; Farewell VT
    Biometrics; 1994 Dec; 50(4):1146-52. PubMed ID: 7786995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and analysis of group sequential logrank tests in maximum duration versus information trials.
    Kim K; Boucher H; Tsiatis AA
    Biometrics; 1995 Sep; 51(3):988-1000. PubMed ID: 7548714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Group sequential methods for comparison of cure rates in clinical trials.
    Lee JW; Sather HN
    Biometrics; 1995 Jun; 51(2):756-63. PubMed ID: 7662857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated confidence intervals for adaptive group sequential trials.
    Mehta CR; Bauer P; Posch M; Brannath W
    Stat Med; 2007 Dec; 26(30):5422-33. PubMed ID: 17918195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of sequential methods in randomized clinical trials with censored response criteria].
    Benichou J; Chastang C
    Rev Epidemiol Sante Publique; 1986; 34(3):196-208. PubMed ID: 3786877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysing sequential events in clinical trials.
    Salter A; Raab G; Day S
    Clin Trials; 2006; 3(5):421-30. PubMed ID: 17060216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential designs for clinical trials in amyotrophic lateral sclerosis.
    Groeneveld GJ; van der Tweel I; Wokke JH; van den Berg LH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Dec; 5(4):202-7. PubMed ID: 15799547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active vaccination after allogeneic bone marrow cell transplantation: a new option in the immunotherapy of cancer?
    Zöller M; Matzku S
    Arch Immunol Ther Exp (Warsz); 2002; 50(3):197-224. PubMed ID: 12098935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential meta-analysis of past clinical trials to determine the use of a new trial.
    Bollen CW; Uiterwaal CS; van Vught AJ; van der Tweel I
    Epidemiology; 2006 Nov; 17(6):644-9. PubMed ID: 17028503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential testing for efficacy in clinical trials with non-transient effects.
    Troendle JF; Liu A; Wu C; Yu KF
    Stat Med; 2005 Nov; 24(21):3239-50. PubMed ID: 16206248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interim analyses for randomized clinical trials: the group sequential approach.
    Pocock SJ
    Biometrics; 1982 Mar; 38(1):153-62. PubMed ID: 7082757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal continuous sequential boundaries for monitoring toxicity in clinical trials: a restricted search algorithm.
    Goldman AI; Hannan PJ
    Stat Med; 2001 Jun; 20(11):1575-89. PubMed ID: 11391689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stopping a clinical trial very early based on unplanned interim analyses: a group sequential approach.
    Emerson SS
    Biometrics; 1995 Sep; 51(3):1152-62. PubMed ID: 7548699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome.
    Zhao Y; Grambsch PM; Neaton JD
    Clin Trials; 2007; 4(2):140-53. PubMed ID: 17456513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.